# The First Affiliated Hospital of University of Science and Technology of China

Organization · id `cardio:org-the-first-affiliated-hospital-of-university-of-science-and-03d159` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=The+First+Affiliated+Hospital+of+University+of+Science+and+Technology+of+China>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 9 trials in this atlas.

## Technical summary

Sponsor class other. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: The First Affiliated Hospital of University of Science and Technology of China
- Sponsor class: OTHER

## Connected pages

- Sponsors: Intra-arterial TNK Following Endovascular Thrombectomy in Patients With Large Vessel Occlusion of Posterior Circulation (`cardio:ct-nct05684172`)
- Sponsors: Intravenous Tenecteplase Plus EVT Versus EVT Alone on 4.5 to 24 Hours After Basilar Artery Occlusion (`cardio:ct-nct05701956`)
- Sponsors: Endovascular Thrombectomy Alone Versus Intravenous Thrombolysis Plus Thrombectomy on Acute Basilar Artery Occlusion (`cardio:ct-nct05827042`)
- Sponsors: Advancing Stroke Safety and Efficacy Through Early Tirofiban Administration After Intravenous Thrombolysis (ASSET-IT) (`cardio:ct-nct06134622`)
- Sponsors: Safety and Efficacy of Remote Ischemic Conditioning in Patients With Severe Stenosis or Occlusion of Anterior Intracranial Circulation Vessels (`cardio:ct-nct06823128`)
- Sponsors: Tenecteplase vs Medical Management in 4.5-24h LVO no Access to EVT (`cardio:ct-nct07168278`)
- Sponsors: Safety and Efficacy of Baricitinib After Endovascular Treatment in Acute Anterior Circulation Large Vessel Occlusion: A Multicenter, Randomized Controlled Clinical Trial (`cardio:ct-nct07449910`)
- Sponsors: GLP-1 Receptor Agonist in Primary Intracerebral Hemorrhage: A Phase 2 Randomized Trial (`cardio:ct-nct07613437`)
- Sponsors: Intravenous Thrombolysis, Endovascular Treatment, or Bridging Therapy for Medium Vessel Occlusion Stroke Within 24 Hours (`cardio:ct-nct07931807`)

## Provenance

Content hash: e3e7d1e6be178b011e3b534c5541f7f7b59feb190a3d3e20d4b0ba6dcc7e58cc
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
